Literature DB >> 10602944

MR imaging of the male pelvis.

J O Barentsz1, M R Engelbrecht, J A Witjes, J J de la Rosette, M van der Graaf.   

Abstract

Prostate and urinary bladder cancer are the most frequently encountered malignancies of the urinary tract. Appropriate use of the different imaging techniques is crucial for accurate assessment of prognosis and for the development of appropriate treatment planning. Especially determination of local tumor extension and detection of nodal or bone metastases is extremely important. In this regard MR imaging is the most promising imaging technique. Therefore, in this review its role in staging these malignancies is evaluated and compared with clinical staging, and other imaging techniques. Finally, future developments, such as new sequences, new contrast agents, the role of surface coils and MR-guided biopsy, are considered. Also, the preferred radiological approach is discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10602944     DOI: 10.1007/s003300050916

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  21 in total

Review 1.  Preoperative imaging for staging bladder cancer.

Authors:  Maxim J McKibben; Michael E Woods
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

2.  Comparing RECIST with EORTC criteria in metastatic bladder cancer.

Authors:  Hakan Öztürk
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-25       Impact factor: 4.553

Review 3.  Update on use of enhanced imaging to optimize lymphadenectomy in patients undergoing minimally invasive surgery for urothelial cancer of the bladder.

Authors:  Lukas Lusuardi; Günter Janetschek
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

4.  Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.

Authors:  Pierpaolo Alongi; Federico Caobelli; Roberta Gentile; Alessandro Stefano; Giorgio Russo; Domenico Albano; Sergio Baldari; Maria Carla Gilardi; Massimo Midiri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-26       Impact factor: 9.236

Review 5.  Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology.

Authors:  Nima Nassiri; Shyam Natarajan; Daniel J Margolis; Leonard S Marks
Journal:  Urology       Date:  2015-07-10       Impact factor: 2.649

6.  The influence of post-diuretic late phase imaging in visual and quantitative evaluation of urothelial tumors by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Zehra Pınar Koç; Pelin Özcan Kara; Emel Sezer; Kadir Eser
Journal:  Turk J Urol       Date:  2019-12-01

7.  MR cystography for bladder tumor detection.

Authors:  Ambros Beer; Bettina Saar; Niko Zantl; Thomas M Link; Rudolf Roggel; Su-Lin Hwang; Hartwig Schwaibold; Ernst J Rummeny
Journal:  Eur Radiol       Date:  2004-08-20       Impact factor: 5.315

Review 8.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.

Authors:  John Kurhanewicz; Mark G Swanson; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

9.  Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival.

Authors:  Sebastian Christoph Schmid; Tina Zahel; Bernhard Haller; Thomas Horn; Ilja Metzger; Konstantin Holzapfel; Anna K Seitz; Jürgen Erich Gschwend; Margitta Retz; Tobias Maurer
Journal:  World J Urol       Date:  2015-08-11       Impact factor: 4.226

Review 10.  Imaging in genitourinary cancer from the urologists' perspective.

Authors:  P Tsakiris; J de la Rosette
Journal:  Cancer Imaging       Date:  2007-05-28       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.